May closed with 35,701 new cases of COVID-19 and 311 deaths from the disease, figures higher than those registered in April and the highest in the whole pandemic in Cuba, the Ministry of Public Health ( MINSAP by its Spanish acronym) reported today in Havana.

A study carried out in patients with esophageal cancer, treated with the monoclonal antibody nimotuzumab (CIMAher), together with chemoradiotherapy, confirmed that this combination produces good results in terms of objective response and survival.

Protecting children and adolescents has been a call reiterated by Cuban health authorities since the COVID-19 pandemic outbroke into the country in March 2020, however, on this International Children's Day the claim acquires greater relevance in view of the increase of cases in pediatric ages.

Cuba studied 20,474 samples of COVID 19, resulting in 1057 positive ones. The country accumulates 4, 349,338 samples taken and 143,323 positive.

The Center for the Management of the health intervention in groups and territories at risk with Cuban vaccine candidates, in Havana, ensures the proper functioning of this unprecedented process in the country, given its great scope and impact in the confrontation of the COVID-19.

Over one million people in Cuba have received at least one dose of the vaccine candidates Soberana 02 and Abdala. This figure includes those who have been vaccinated as part of clinical trials, intervention studies in at-risk groups and health intervention in at-risk groups and territories that are currently being carried out.

Some 1 thousand 100 new health professionals will graduate next July at the Medical University of eastern Granma province as a result of a restructuring of the school year in that territory due to the impact by the COVID-19.

On the occasion of today's celebration of World Smoke-Free Day, Cuban public health minister, Jose Angel Portal Miranda, called on Twitter to raise awareness about the harmful and lethal effects of this habit.

As a result of the health interventions, clinical trials and intervention studies carried out so far with Cuban vaccine candidates against COVID-19, more than one million people have received an immunogen, informed today Dr. Francisco Duran, national director of epidemiology of the ministry of public health ( MINSAP by its Spanish acronym).

The brigade of the Henry Reeve International Contingent of Doctors Specialized in Situations of Disasters and Serious Epidemics that worked in Suriname, returned on Sunday to Cuba after contributing to the fight against the COVID-19 pandemic in that South American nation.

Medicines such as HeberFERON, Heberon Alfa R and Nasalferon, which are in great demand in the country in the fight against the COVID-19 pandemic, are now a reality thanks to a group of researchers who 40 years ago obtained the first interferon, an initial step in the development of Cuban biotechnology.

Cuba studied 21,978 samples of COVID 19, resulting in 1,169 positive ones. The country accumulates 4, 260,156,156 samples taken and 138,899 positive.

After seven hours and 45 minutes of a complex surgical intervention to correct an isolated craniosynostosis (fusion of bones), a multidisciplinary team from the Eliseo Noel Caamaño pediatric hospital in Matanzas(western Cuba) saved the life of baby David Alejandro Pujol Moreno, who was only three months old.

In the last 15 days, 2,688 pediatric patients have been diagnosed in Cuba with the SARS-CoV-2 virus, with a 179 daily average report.